A Focus on the Nowadays Potential Antiviral Strategies in Early Phase of Coronavirus Disease 2019 (Covid-19): A Narrative Review
<b>Background</b>: The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the related disease (COVID-19) has rapidly spread to a pandemic proportion, increasing the demands on health systems for the containment and management of COVID-19. Nowadays,...
Main Authors: | Caterina Monari, Valeria Gentile, Clarissa Camaioni, Giulia Marino, Nicola Coppola, Vanvitelli COVID-19 group |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/10/8/146 |
Similar Items
-
Revolutionizing Antiviral Therapeutics: Unveiling Innovative Approaches for Enhanced Drug Efficacy
by: Megantara S, et al.
Published: (2024-03-01) -
Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs
by: Emily L.C. Tan, et al.
Published: (2004-04-01) -
Treating ocular toxoplasmosis: current evidence
by: MR Stanford, et al.
Published: (2009-03-01) -
Antivirals for Broader Coverage against Human Coronaviruses
by: Mia Outteridge, et al.
Published: (2024-01-01) -
Current Situation and Progress of Evidence Synthesis Methodology
by: SU Renfeng, et al.
Published: (2023-11-01)